{
    "organizations": [],
    "uuid": "8b1b488b4a2442c3d16b05c92d6e016b72dec2a7",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/01/24/pr-newswire-biomarin-to-host-fourth-quarter-and-full-year-2017-financial-results-conference-call-and-webcast-on-thursday-february-22-at.html",
    "ord_in_thread": 0,
    "title": "BioMarin to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast on Thursday, February 22 at 4:30pm ET",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SAN RAFAEL, Calif., Jan. 24, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, February 22, at 4:30 p.m. ET to discuss fourth quarter and full year 2017 financial results and provide a general business update.\nDial-in Number\nU.S. / Canada Dial-in Number: (866) 502-9859\nInternational Dial-in Number: (574) 990-1362\nConference ID: 5289587\nReplay Dial-in Number: (855) 859-2056\nReplay International Dial-in Number: (404) 537-3406\nConference ID: 5289587\nInterested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com . A replay of the call will be archived on the site for one week following the call.\nAbout BioMarin\nBioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com .\nContacts:\nInvestors\nMedia\nTraci McCarty\nDebra Charlesworth\nBioMarin Pharmaceutical Inc.\nBioMarin Pharmaceutical Inc.\n(415) 455-7558\n(415) 455-7451\nView original content with multimedia: http://www.prnewswire.com/news-releases/biomarin-to-host-fourth-quarter-and-full-year-2017-financial-results-conference-call-and-webcast-on-thursday-february-22-at-430pm-et-300586781.html\nSOURCE BioMarin Pharmaceutical Inc.",
    "published": "2018-01-24T16:30:00.000+02:00",
    "crawled": "2018-01-24T16:51:30.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "san",
        "rafael",
        "biomarin",
        "pharmaceutical",
        "nasdaq",
        "bmrn",
        "today",
        "announced",
        "bienaimé",
        "chairman",
        "chief",
        "executive",
        "officer",
        "biomarin",
        "host",
        "conference",
        "call",
        "webcast",
        "thursday",
        "february",
        "et",
        "discus",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "provide",
        "general",
        "business",
        "update",
        "number",
        "canada",
        "number",
        "international",
        "number",
        "conference",
        "id",
        "replay",
        "number",
        "replay",
        "international",
        "number",
        "conference",
        "id",
        "interested",
        "party",
        "may",
        "access",
        "live",
        "audio",
        "webcast",
        "conference",
        "call",
        "via",
        "investor",
        "section",
        "biomarin",
        "website",
        "replay",
        "call",
        "archived",
        "site",
        "one",
        "week",
        "following",
        "call",
        "biomarin",
        "biomarin",
        "global",
        "biotechnology",
        "company",
        "develops",
        "commercializes",
        "innovative",
        "therapy",
        "patient",
        "serious",
        "rare",
        "genetic",
        "disease",
        "company",
        "portfolio",
        "consists",
        "six",
        "commercialized",
        "product",
        "multiple",
        "clinical",
        "product",
        "candidate",
        "additional",
        "information",
        "please",
        "visit",
        "contact",
        "investor",
        "medium",
        "traci",
        "mccarty",
        "debra",
        "charlesworth",
        "biomarin",
        "pharmaceutical",
        "biomarin",
        "pharmaceutical",
        "view",
        "original",
        "content",
        "multimedia",
        "http",
        "source",
        "biomarin",
        "pharmaceutical",
        "inc"
    ]
}